Current and prospective pharmacotherapy for autoimmune hepatitis
- PMID: 24961409
- DOI: 10.1517/14656566.2014.931938
Current and prospective pharmacotherapy for autoimmune hepatitis
Abstract
Introduction: Corticosteroids alone or in combination with azathioprine are the mainstay therapies of autoimmune hepatitis. Suboptimal responses (treatment failure, partial response, drug toxicity), frequent relapse after drug withdrawal, and the emergence of alternative immunosuppressive medications have fueled the pursuit of new treatments. The goals of this review are to present current management strategies and evolving interventions.
Areas covered: PubMed searches from 1970 - 2014 provide the bases for this review. Corticosteroid regimens should be administered until resolution of symptoms, laboratory tests, and liver tissue abnormalities. Treatment failure warrants high doses of the original regimen, and relapse warrants re-treatment followed by long-term maintenance with azathioprine. The calcineurin inhibitors, budesonide, and mycophenolate mofetil are evolving as frontline therapies, and they may be considered as salvage therapies with the exception of budesonide. Rapamycin, rituximab, and infliximab have also rescued refractory patients but experiences are limited. Anti-oxidants, recombinant molecules, mAbs, and modulators of critical cell populations are key prospects.
Expert opinion: Autoimmune hepatitis must be managed by multiple medications that supplement or supplant current regimens depending on the clinical situation. Rescue therapies will emerge as adjunctive interventions to minimize tissue damage (prevent fibrosis and hepatocyte apoptosis) and improve immune tolerance (regulatory T cell manipulations).
Keywords: autoimmune hepatitis; immunosuppressive drugs; mAbs; recombinant molecules; treatments.
Similar articles
-
Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.An Bras Dermatol. 2014 Nov-Dec;89(6):980-4. doi: 10.1590/abd1806-4841.20143128. An Bras Dermatol. 2014. PMID: 25387507 Free PMC article.
-
Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.Inflamm Allergy Drug Targets. 2012 Oct;11(5):337-50. doi: 10.2174/187152812803251006. Inflamm Allergy Drug Targets. 2012. PMID: 22563779 Review.
-
Treatment of Autoimmune Hepatitis.Clin Liver Dis. 2024 Feb;28(1):51-61. doi: 10.1016/j.cld.2023.07.001. Epub 2023 Aug 25. Clin Liver Dis. 2024. PMID: 37945162 Review.
-
Current and future treatments of autoimmune hepatitis.Expert Rev Gastroenterol Hepatol. 2009 Jun;3(3):269-91. doi: 10.1586/egh.09.15. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19485809 Review.
-
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.J Clin Gastroenterol. 2005 Oct;39(9):819-25. doi: 10.1097/01.mcg.0000177260.72692.e8. J Clin Gastroenterol. 2005. PMID: 16145346
Cited by
-
Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis-The 20-Year Experience of a High-Volume Tertiary Center.J Clin Med. 2023 Jun 21;12(13):4192. doi: 10.3390/jcm12134192. J Clin Med. 2023. PMID: 37445225 Free PMC article.
-
Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial.JGH Open. 2019 Sep 10;4(3):371-377. doi: 10.1002/jgh3.12258. eCollection 2020 Jun. JGH Open. 2019. PMID: 32514439 Free PMC article.
-
Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.Gut Liver. 2016 Mar;10(2):177-203. doi: 10.5009/gnl15352. Gut Liver. 2016. PMID: 26934884 Free PMC article. Review.
-
Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation.Drug Des Devel Ther. 2016 Jan 25;10:443-53. doi: 10.2147/DDDT.S92440. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26869766 Free PMC article.
-
Update on the Teratogenicity of Maternal Mycophenolate Mofetil.J Pediatr Genet. 2015 Jun;4(2):42-55. doi: 10.1055/s-0035-1556743. J Pediatr Genet. 2015. PMID: 27617117 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical